Geisinger Health System gets approval for $300M in tax-exempt bonds; What will the nation be like a year from now?;

> In what could be another sign that the bond market is thawing a bit, Geisinger Health System has announced that it's seeking approval for up to $300 million in tax-exempt bonds. It's all part of a continuing growth spurt for the system, which plans to add 1,500 jobs over the next five years. FierceHealthFinance

> Hospital Impact's Tony Chen wonders what we'll be talking about a year from now, given the current conditions throughout the nation. Hospital Impact

> President Obama appears ready to call for a regulatory pathway to approve generic biotech therapies, also known as biosimilars. That move would have a major impact on a biotech company like Amgen, which has anemia drugs that will quickly face new generic competition. FierceBiotech

And Finally... In Denver, at least, this is what you get for saving someone's life. Article